drugset / Trial / NCT01935557

Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

NCT01935557

Phase 3 Completed 296 enrolled Yong Seog Oh
RandomizedParallel-groupSingle-blindTreatment

Summary

Optimal anticoagulation using heparin with close attention to maintain therapeutic dosing during the procedure is important. Randomized comparison of continuous and intermittent heparin infusion during catheter ablation of Atrial Fibrillation.

Timeline

Start
2012-12
Primary completion
2015-07
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 100 iu/kg Intravenous